RecruitingNCT06638320

Hepatitis Delta Virus Infection: Cross-sectional Study in Patients With Chronic Hepatitis B Virus Infection


Sponsor

Tam Anh Research Institute

Enrollment

2,452 participants

Start Date

Nov 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational study is to determine the prevalence of hepatitis D virus (HDV) and the distribution of the HDV genotype in patients with chronic hepatitis B infection. It will also identify factors related to hepatitis D virus infection, such as characteristics of the study sample, vaccination history, drug use affecting hepatitis, family factors, environment, and lifestyle. This study will be conducted at Tam Anh General Hospital, Bach Mai Hospital and Tam Anh TP. Ho Chi Minh General Hospital. Participants will be interviewed directly through a questionnaire to collect some information related to epidemiological risk factors. A blood sample will also be collected.


Eligibility

Min Age: 16 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with chronic hepatitis b and hepatitis delta with hepatitis b carrier state. The study is currently recruiting participants at 3 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(3)

Bach Mai General Hospital

Hà Nội, Northern Vietnam, Vietnam

Tam Anh General Hospital

Hà Nội, Northern Vietnam, Vietnam

Tam Anh TP. Ho Chi Minh General Hospital

Ho Chi Minh City, Southern Vietnam, Vietnam

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06638320


Related Trials